Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids-Reference-Cited by-同舟云学术

Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids

Published:2020-02 Issue: Volume:319 Page:148-154
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Kamble Shyam H.,Sharma Abhisheak,King Tamara I.^ORCID,Berthold Erin C.,León Francisco^ORCID,Meyer P. Katharina L.,Kanumuri Siva Rama Raju,McMahon Lance R.,McCurdy Christopher R.,Avery Bonnie A.

Funder

National Institute on Drug Abuse

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference39 articles.

1. The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective;Bjornsson;Drug Metab. Dispos.,2003

2. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth);Boyer;Addiction,2008

3. Selective inhibition of cytochrome P450 2D6 by Sarpogrelate and its active metabolite, M-1, in human liver microsomes;Cho;Drug Metab. Dispos.,2014

4. Following “the Roots” of Kratom (Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in southeast asia to a recreational psychoactive drug in western countries;Cinosi;Biomed Res. Int.,2015

5. Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis;Copeland,2000

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beneficial and adverse health effects of kratom (Mitragyna speciosa): A critical review of the literature;Food and Chemical Toxicology;2024-10

2. Effects of polyphenols extracted from Keemun black tea on CYP450s activity and molecular mechanisms;Food Science & Nutrition;2024-07-19

3. Kratom: a primer for pain physicians;Current Opinion in Anaesthesiology;2024-07-08

4. Kratom (Mitragynia speciosa), seizure latency, anxiety, and “social” behavior in the zebrafish;Pharmacy & Pharmacology International Journal;2024-04-29

5. Rehmannioside A inhibits the activity of CYP3A4, 2C9 and 2D6 in vitro;Xenobiotica;2024-03-04